Candice Sun

Eisai (China) Pharmaceutical Co., Ltd.

Eisai's enterprises in China are affiliated to Eisai Co., Ltd. Eisai Co., Ltd. is a multinational company mainly engaged in the research and development of pharmaceutical products, headquartered in Tokyo, Japan, and headquartered in Shanghai in China. Eisai has grown smoothly since entering the Chinese market in the early 1990s, with a total registered capital of US$108.54 million in China. Its member companies include Eisai (China) Investment Co., Ltd., Eisai (China) Pharmaceutical Co., Ltd., Eisai ( Liaoning) Pharmaceutical Co., Ltd., Eisai (Suzhou) Trading Co., Ltd., Jingyi Weixiang (Shanghai) Health Industry Development Co., Ltd. (joint venture), etc., have formed key areas of neuroscience, tumor (special medicine), digestive liver disease, and expanded Other areas, such as generic drugs, sell as many as dozens of drugs and other products. In 2018, the new factory located in Xingpu Road, Suzhou Industrial Park was officially put into operation, with a plant area of ​​23,000 square meters, a designed annual production capacity of 3 billion tablets and packaging of 5 billion tablets, and the production capacity has been rapidly increased. As one of the main factories of the group, in the future, the products produced by the Suzhou factory will not only meet the needs of the Chinese market, but also supply 23 countries and regions in East Asia, Southeast Asia, the Middle East, Central and South America, and Europe. All of Eisai's enterprises in China adhere to the corporate tenet of hhc (human health care, care about human health), take Compliance as the code of conduct, and GMP as the quality standard to provide patients and their families with high-quality, environmental protection, safety and satisfaction. products and services. At the same time, it actively undertakes corporate social responsibilities. In 2020, it has donated a total of more than 15 million yuan in cash and medical supplies to fight against the new crown pneumonia epidemic; The funding amount exceeds 9 million yuan; since 2013, the donation amount of the "Remember I Love You Yellow Bracelet" project in cooperation with the Population Welfare Foundation has exceeded 5 million yuan, which has benefited 250,000 high-risk senile dementia patients; since 2014 to In 2019, nearly 3 million yuan of medicines were donated through the "Three Sanitation Going to the Countryside" activities; so far, in cooperation with the China Primary Health Care Foundation, more than 2 billion yuan of medicines have been provided free of charge to cancer patients and families to solve the problems of patients The family burden has greatly improved the accessibility and affordability of patients using innovative drugs, and has been awarded "Shanghai Civilized Unit", "China Outstanding Employer", "Great Suzhou Best Employer", "China Pharmaceutical Industry Top 100", "Promoting Medical Public Welfare and Fulfilling Corporate Mission" Annual Enterprise and other honorary titles.